Skip Page Header

Home > Opioid agonist therapy: a synthesis of Canadian guidelines for treating opioid use disorder.

Centre for Addiction and Mental Health. (2021) Opioid agonist therapy: a synthesis of Canadian guidelines for treating opioid use disorder. Toronto: Centre for Addiction and Mental Health.

[img]
Preview
PDF (Opioid agonist therapy: a synthesis of Canadian guidelines for treating opioid use disorder)
2MB

Canada is in the midst of an opioid crisis, making it important to disseminate standardized approaches and evidence-based recommendations for managing opioid use disorder. This is a national clinical guideline that harmonizes existing provincial and national guidelines, evidence-based practices and expert opinions into one document aimed at providing consistent and high-quality care to people with opioid use disorder.

Opioid agonist therapy is the most effective treatment option for opioid use disorder, ideally combined with behavioural and social supports. It can stabilize the cycle of intoxication and withdrawal, reduce opioid cravings and block the intoxicating effects of other short-acting opioids, including fentanyl. People who are maintained on opioid agonist therapy typically experience improved health and social functioning and reduced risk of overdose.

Item Type
Report
Publication Type
International, Guideline, Report
Drug Type
Opioid
Intervention Type
Drug therapy, Treatment method, Harm reduction
Date
May 2021
Pages
52 p.
Publisher
Centre for Addiction and Mental Health
Corporate Creators
Centre for Addiction and Mental Health
Place of Publication
Toronto
EndNote
Related (external) link

Repository Staff Only: item control page